Author:
Huang Yu-Sen,Chen Jenny Ling-Yu,Chen Jo-Yu,Lee Yee-Fan,Huang Jei-Yie,Kuo Sung-Hsin,Yen Ruoh-Fang,Chang Yeun-Chung
Funder
National Taiwan University Hospital
Ministry of Science and Technology, Taiwan
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Radiology Nuclear Medicine and imaging
Reference27 articles.
1. Ramnath N, Dilling TJ, Harris LJ et al (2013) Treatment of stage III non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American college of chest physicians evidence-based clinical practice guidelines. Chest 143:e314S–e340S
2. Postmus PE, Kerr KM, Oudkerk M et al (2017) Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 28:iv1–iv21
3. O’Rourke N, Roque IFM, Farre Bernado N et al (2010) Concurrent chemoradiotherapy in non-small cell lung cancer. Cochrane Database Syst Rev.
https://doi.org/10.1002/14651858.CD002140.pub3
4. Warner A, Dahele M, Hu B et al (2016) Factors associated with early mortality in patients treated with concurrent chemoradiation therapy for locally advanced non-small cell lung cancer. Int J Radiat Oncol Biol Phys 94:612–620
5. Huang YS, Chen JL, Hsu FM et al (2018) Response assessment of stereotactic body radiation therapy using dynamic contrast-enhanced integrated MR-PET in non-small cell lung cancer patients. J Magn Reson Imaging 47:9
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献